| Subjects without TB (n = 1206) | Subjects with latent TB (n = 635) | Subjects with active TB (n = 13) | P-value by ANOVA |
---|---|---|---|---|
Age, mean | 33.0 | 33.5 | 34.1 | 0.5102 |
Male, % (n) | 247 (20.5%) | 193 (30.4%) | 3 (23.1%) | < 0.0001 |
CD4 cells/mm3, mean | 455 | 502 | 376 | 0.0001 |
HIV viral load, copies/mL, mean | 37,286 | 28,365 | 87,293 | 0.0063 |
Previous TB, % (n) | 98 (8.1%) | 61 (9.6%) | 2 (15.4%) | 0.3865 |
On antiretrovirals, % (n) | 44 (3.6%) | 13 (2.0%) | 0 (0%) | 0.1366 |
TST, mm, mean | 0.2 | 15.5 | 15.0 | < 0.0001 |
TST ≥ 5 mm, % (n) | 0 (0%) | 635 (100%) | 11 (84.6%) | < 0.0001 |
MAS, mm, mean | 0.3 | 9.6 | 10.1 | < 0.0001 |
MAS ≥ 5 mm, % (n) | 835 (69.2%) | 582 (91.7%) | 10 (76.9%) | < 0.0001 |